A novel 3-dimensional culture system as an in vitro model for studying oral cancer cell invasion

International Journal of Experimental Pathology

Volumn 86, Issue 6, 2005, Pages 365-374

  Duong, Hai S ^a   Le, Anh D ^b,c   Zhang, Qunzhou ^b   Messadi, Diana V ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

3 D construct; Hypoxia; Opticell chamber; Oral cancer invasion

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR; UROKINASE RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; HYPOXIA; MICROSCOPY; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ZYMOGRAPHY;

BLOTTING, WESTERN; CELL HYPOXIA; COCULTURE TECHNIQUES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBROBLASTS; HUMANS; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; URINARY PLASMINOGEN ACTIVATOR;

EID: 28544446518     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.0959-9673.2005.00441.x     Document Type: Article

References (38)

1. Albini A., Iwamoto Y., Kleinman H.K. et al. (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer. Res. 47, 3239-3245.
2. Andreasen P.A., Egelund R., Petersen H.H. (2000) The plasminogen activation system in tumor growth, invasion and metastasis. Cell. Mol. Life. Sci. 57, 25-40.
3. Andriani F., Garfield J., Fusenig N.B., Garlick J.A. (2004) Basement membrane proteins promote progression of intra-epithelial neoplasia in 3-dimensional models of human stratified epithelium. Int. J. Cancer. 108, 348-357.
4. Bosserhoff A.K., Echtenacher B., Hein R., Buettner R. (2001) Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo. Melanoma. Res. 11, 417-421.
5. Brown J.M. (2000) Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol. Med. Today. 6, 157-162.
6. Buchler P., Reber H.A., Lavey R.S. et al. (2004) Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model. J. Surg. Res. 120, 295-303.
7. Cajot J.F., Bamat J., Bergaonzelli G.E. et al. (1990) Plasminogen activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells. Proc. Natl. Acad. Sci. USA. 87, 6939-6943.
8. Camps J.L., Chang S.M., Hsu T.C. et al. (1990) Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc. Natl. Acad. Sci. USA. 87, 75-79.
9. Canning M.T., Postovit S., Clarke S.H., Graham C.H. (2001) Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells. Exp. Cell. Res. 267 (1), 88-94.
10. Choi N. & Kim S. (2000) Two fibrin zymography methods for analyis of plasminogen activators on gels. Anal. Biochem. 281, 236-238.
11. Del Rosso M., Fibbi G., Pucci M. et al. (2002) Multiple pathways of cell invasion are regulated by multiple families of serine proteases. Clin. Exp. Metastasis. 19 (3), 193-207.
12. Dimova E.Y., Samoylenko A., Kietzmann T. (2004) Oxidative stress and hypoxia: implications for plasminogen activator inhibitor-1 expression. Antioxid. Redox. Signal. 6 (4), 777-791.
13. Durand M.K.V., Bodker J.S., Christensen A. et al. (2004) Plasminogen Activator inhibitor-1 and tumor growth, invasion and metastasis. Thromb. Haemost. 91, 438-449.
14. Elenbaas B. & Weinberg R.A. (2001) Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell. Res. 264, 169-184.
15. Graham C.H., Forsdike J., Fitzgerald CJ., Macdonald-Goodfellow S. (1999) Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int. J. Cancer. 80 (4), 617-623.
16. Harris A.L. (2002) Hypoxia-key regulatory factor in tumour growth. Nat. Rev. Cancer. 2, 38-47.
17. Hockel M. & Vaupel P. (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer. Inst. 93, 266-276.
18. Kiaris H., Chatzistamou I, Kalofoutis C.H., Koutselini H., Piperi C.H., Kalofoutis A. (2004) Tumour-stroma interactions in carcinogenesis: basic aspects and perspectives. Mol. Cell. Biochem. 26 (1), 117-122.
19. Koong A.C., Denko N.C., Hudson K.M. et al. (2000) Candidate genes for the hypoxic tumor phenotype. Cancer. Res. 20, 883-887.
20. Kunz-Schughart L.A. & Knuechel R. (2002) Tumor-associated fibroblast (Part II): functional impact on tumor tissue. Histol. Histopathol. 17, 623-637.
21. Kurokawa T.A., Miyamoto M., Kato K. et al. (2003) Overexpression of hypoxia-inducible factor-1 alpha in oeso-phageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br. J. Cancer. 89 (6), 1042-1047.
22. Lee K.H., Choi E.Y., Hyun M.S., Kim J.R. (2004) Involvement of MAPK pathway in hypoxia-induced upregulation of urokinase plasminogen activator receptor in a human prostatic cancer cell line, PC3MLN4. Exp. Mol. Med. 36 (1), 57-64.
23. Matrisian L.M., Cunha G.R., Mohla S. (2001) Epithelial-stromal interactions and tumor progression: meeting summary and future directions. Cancer. Res. 61, 3844-3846.
24. Mignati P. & Rifkin D.B. (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73, 161-195.
25. Morita S., Sato A., Hayakawa H. et al. (1998) Cancer cells over-express mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small-cell lung cancer tissue: analysis by northern blotting and in situ hybridization. Int. J. Cancer. 78, 286-292.
26. Plasswilm L., Tannapfel A., Cordes N. et al. (2000) Hypoxia-induced tumor cell migration in an in vivo chicken model. Pathobiology 68 (3), 99-105.
27. Rofstad E.K., Rasmussen H., Galappathi K., Mathiesen B., Nielsen K., Graff B.A. (2002) Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. Cancer Res. 62 (6), 1847-1853.
28. Rosenthal E.L., McCrory A., Talbert M., Carroll W., Magnuson J.S., Peters G.E. (2004) Expression of proteolytic enzymes in head and neck cancer-associated fibroblasts. Arch. Otolaryngol. Head. Neck. Surg. 130, 943-947.
29. Rubin H. (2001) Selected cell and selective microenviroment in neoplastic development. Cancer Res. 61, 799-807.
30. Semenza G.L. (2002) HIF-1 and tumor progression: pathophysiology and therapeutics. Trends. Mol. Med. 8 (4), S62-S67.
31. Subarsky P. & Hill R.P. (2003) The hypoxic tumor microenvironment and metastatic progression. Clin. Exp Metastasis. 20 (3), 237-250.
32. Tuan T.L., Wu H., Huang E.Y. et al. (2003) Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures. Am. J. Pathol. 162, 1579-1589.
33. Vaccariello M., Javaherian A., Wang Y., Fuesing N.E., Garlick J.A. (1999) Cell interactions control the fate of malignant keratinocytes in an organotypic model of early neoplasia. J. Invest Dermatol. 113, 384-391.
34. Wang Z. & Kurpakas-Wheater M. (2003) Decreased plasminogen activator inhibitor-1 secretion in hypoxic corneal epithelial cells is associated with increased urokinase plasmingen activator activity. Int. J. Biochem. Cell. Biol. 35, 339-348.
35. Whitley B.R., Palmieri D., Twerdi C.D., Church F.C. (2004) Expression of active plasminogen activator inhibitor - 1 reduces cell migration and invasion in breast and gynecological cancer cells. Exp. Cell. Res. 296, 151-162.
36. Zhang Y., Lu H., Dazin P., Kapila Y. (2004) Functional differences between integrin 4 and integrins 5/v in modulating the motility of human oral squamous carcinoma cells in response to the V region and heparin-binding domain of fibronectin. Exp. Cell. Res. 15, 48-58.
37. Zhong H., De Marzo A.M., Laughner E. et al. (1999) Overexpression of hypoxia-inducible factor-1alpha in common human cancers and their metastases. Cancer. Res. 59 (22), 5830-5835.
38. Ziober B.L., Turner M.A., Palefsky J.M., Banda M.J., Kramer R.H. (2000) Type I collagen degradation by invasive oral squamous cell carcinoma. Oral. Oncol. 36, 365-372.